Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Lager risico op abnormaal uterien bloedverlies met dabigatran ten opzichte van warfarine
jan 2017